Veeva Systems Inc. $VEEV Shares Sold by TD Asset Management Inc

TD Asset Management Inc trimmed its holdings in Veeva Systems Inc. (NYSE:VEEV) by 21.7% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 392,174 shares of the technology company’s stock after selling 108,472 shares during the quarter. TD Asset Management Inc’s holdings in Veeva Systems were worth $112,938,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in VEEV. Axxcess Wealth Management LLC lifted its stake in Veeva Systems by 6.1% in the second quarter. Axxcess Wealth Management LLC now owns 1,358 shares of the technology company’s stock valued at $391,000 after buying an additional 78 shares during the last quarter. NorthRock Partners LLC purchased a new stake in Veeva Systems in the second quarter valued at approximately $504,000. Sequoia Financial Advisors LLC lifted its stake in Veeva Systems by 10.3% in the second quarter. Sequoia Financial Advisors LLC now owns 21,392 shares of the technology company’s stock valued at $6,161,000 after buying an additional 1,999 shares during the last quarter. MGO One Seven LLC lifted its stake in Veeva Systems by 22.0% in the second quarter. MGO One Seven LLC now owns 3,992 shares of the technology company’s stock valued at $1,150,000 after buying an additional 719 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its stake in Veeva Systems by 4.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 82,405 shares of the technology company’s stock valued at $23,312,000 after buying an additional 3,156 shares during the last quarter. 88.20% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the completion of the transaction, the insider owned 23,773 shares in the company, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the transaction, the insider owned 25,325 shares of the company’s stock, valued at $7,765,151.50. The trade was a 19.15% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 24,665 shares of company stock worth $7,438,000. 10.30% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of brokerages have weighed in on VEEV. Truist Financial boosted their price objective on Veeva Systems from $268.00 to $275.00 and gave the company a “hold” rating in a research note on Thursday, August 28th. Raymond James Financial reiterated an “outperform” rating and issued a $340.00 price objective (up previously from $310.00) on shares of Veeva Systems in a research note on Thursday, August 28th. Citigroup boosted their price objective on Veeva Systems from $329.00 to $349.00 and gave the company a “buy” rating in a research note on Thursday, August 28th. BTIG Research upped their price target on Veeva Systems from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Thursday, August 28th. Finally, Wall Street Zen upgraded Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Veeva Systems presently has an average rating of “Moderate Buy” and a consensus price target of $307.58.

Veeva Systems Stock Performance

NYSE:VEEV opened at $287.81 on Wednesday. The stock has a fifty day moving average price of $283.06 and a two-hundred day moving average price of $265.77. The stock has a market capitalization of $47.17 billion, a price-to-earnings ratio of 59.10, a PEG ratio of 2.21 and a beta of 0.98. Veeva Systems Inc. has a 1 year low of $201.54 and a 1 year high of $310.50.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.90 by ($0.64). The business had revenue of $789.08 million during the quarter, compared to analysts’ expectations of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The company’s revenue was up 16.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. On average, analysts predict that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.